Form 8-K - Current report:
SEC Accession No. 0001564590-21-029621
Filing Date
2021-05-25
Accepted
2021-05-25 09:04:42
Documents
13
Period of Report
2021-05-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-8k_20210524.htm   iXBRL 8-K 43402
2 EX-10.1 hrtx-ex101_6.htm EX-10.1 571268
  Complete submission text file 0001564590-21-029621.txt   844727

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20210524.xsd EX-101.SCH 5772
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20210524_lab.xml EX-101.LAB 19484
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20210524_pre.xml EX-101.PRE 11633
6 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-8k_20210524_htm.xml XML 3563
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 21958236
SIC: 2834 Pharmaceutical Preparations